Cigarette smoke reduces the efficacy of cisplatin in head and neck cancer cells - role of ABCG2.
Anticancer Res. 40, 1277-1284 (2020)
Background/Aim: We evaluated the influence of smoking on head and neck squamous cell carcinomas (HNSCC), which are in their majority tobacco-driven. Tobacco smoke is expected to influence the expression of ABCG2-transporters involved in multidrug resistance. The aim of the study was to evaluate the effect of cigarette smoke condensate (CSC) on ABCG2 expression on HNSCC cells, to demonstrate the adverse effects of cigarette smoke during anticancer treatment in vitro and to assess the prevalence of ABCG2 expression in HNSCC. Materials and methods: HNSCC cell lines were treated with CSC and basal and induced ABCG2 expression was examined. The impact of CSC on cellular viability/proliferation during cytotoxic drug treatment was also evaluated. ABCG2 expression levels in HNSCC were correlated with the smoking history of patients. Results: HNSCC cells showed low basal ABCG2 expression. CSC treatment resulted in a threefold increase in the expression of ABCG2 and in resistance to cisplatin. Tumor samples of never smokers showed significantly higher ABCG2 expression compared to ever smokers. ABCG2 expression correlated with pack years of cigarette consumption. Conclusion: Tobacco consumption is linked to an inducible and increased ABCG2 protein expression and has an impact on drug resistance.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Abcg2 ; Hnscc ; Csc ; Cisplatin ; Pica ; Fadu ; Cigarette Smoke; Human-papillomavirus; Transporter; Expression; Carcinoma; Risk
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
0250-7005
e-ISSN
1791-7530
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 40,
Issue: 3,
Pages: 1277-1284
Article Number: ,
Supplement: ,
Series
Publisher
International Institute of Anticancer Research
Publishing Place
Editorial Office 1st Km Kapandritiou-kalamou Rd Kapandriti, Po Box 22, Athens 19014, Greece
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Radiation Sciences
PSP Element(s)
G-501000-001
G-521800-001
Grants
Copyright
Erfassungsdatum
2020-03-24